Skip to main content
placeholder image

Phase III clinical trials with anamorelin HCl, a novel oral treatment for NSCLC cachexia.

Journal Article


Abstract


Publication Date


  • 2013

Citation


  • Abernethy, A. P., Temel, J. S., Currow, D., Gleich, L. L., & Friend, J. (2013). Phase III clinical trials with anamorelin HCl, a novel oral treatment for NSCLC cachexia.. Journal of Clinical Oncology, 31(15_suppl), tps9649. doi:10.1200/jco.2013.31.15_suppl.tps9649

Web Of Science Accession Number


Start Page


  • tps9649

End Page


  • tps9649

Volume


  • 31

Issue


  • 15_suppl

Place Of Publication


Abstract


Publication Date


  • 2013

Citation


  • Abernethy, A. P., Temel, J. S., Currow, D., Gleich, L. L., & Friend, J. (2013). Phase III clinical trials with anamorelin HCl, a novel oral treatment for NSCLC cachexia.. Journal of Clinical Oncology, 31(15_suppl), tps9649. doi:10.1200/jco.2013.31.15_suppl.tps9649

Web Of Science Accession Number


Start Page


  • tps9649

End Page


  • tps9649

Volume


  • 31

Issue


  • 15_suppl

Place Of Publication